K-pop

Lee Jeok and Kim Jin-pyo Set to Heat Up the End of the Year with a “Panic” Encore Concert

December 4–6 at Kyung Hee University’s Peace Hall

KIM HYUNSIK
2026-10-06 09:07:20
[Edaily Starin KIM HYUNSIK Reporter] Singers Lee Juck and Kim Jin-pyo are teaming up once again as the duo Panic.
Lee Juck (left), Kim Jin-pyo (Photo courtesy of Music Farm)
According to Lee Juck’s agency, Music Farm, on the 6th, Panic will hold a three-day solo concert titled “PANIC IS COMING, AGAIN” from December 4 to 6 at Kyung Hee University’s Peace Hall in Dongdaemun-gu, Seoul.
PANIC, which debuted in 1995, gained popularity with songs such as “Snail,” “Left-Handed,” “UFO,” and “The Sea in My Old Dresser.” Last April, they held “PANIC IS COMING” at the LG Arts Center Seoul in Gangseo-gu, Seoul, reuniting with audiences on stage for the first time in 20 years.
This performance is an encore concert of “Panic Is Coming.” Music Farm stated, “Thanks to the enthusiastic support from fans, Lee Juck and Kim Jin-pyo have decided to take the stage once again,” adding, “The two plan to fill the winter night with passionate energy through Panic’s signature sound, which blends vocals, rap, and piano.”
Music Farm plans to announce the ticket reservation schedule for “Panic Is Coming, Again” via its official social media channels in the near future.

Economy

Corporation

IT·Science

Economy

Japanese Finance Minister Proposes "Combination of Stablecoins, Tokenized Deposits, and Government Bonds"... to Lead a Government-Wide Forum

As the Japanese government moves forward with plans to incorporate crypto assets into the framework of the Financial Instruments and Exchange Act (hereinafter referred to as the FIEA), the government …
2026-11-20 14:30:21

Corporation

curacle co., ltd. Files for U.S. Phase 2b Clinical Trial of CU06, an Oral Treatment for Diabetic Macular Edema

curacle co., ltd.(365270)is moving forward with a U.S. Phase 2b clinical trial to develop an oral treatment for diabetic macular edema (DME). The trial will re-evaluate the treatment’s efficacy in pat…
2026-11-20 13:02:02

IT·Science

Aimed Bio Inc.’s ADC Technology Export Shows 60% Response Rate in Phase 1 Clinical Trial… Moving Forward with U.S. Approval Trials

#Aimed Bio Inc.’s antibody-drug conjugate (ADC) “BHV-1530 (AMB302),” which was licensed to U.S.-based Biohaven, has demonstrated initial anticancer efficacy in a Phase 1 clinical trial. Biohaven plans…
2026-11-20 13:07:02